Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer
β Scribed by Thomas, George V; Tran, Chris; Mellinghoff, Ingo K; Welsbie, Derek S; Chan, Emily; Fueger, Barbara; Czernin, Johannes; Sawyers, Charles L
- Book ID
- 109932793
- Publisher
- Nature Publishing Group
- Year
- 2005
- Tongue
- English
- Weight
- 305 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1078-8956
- DOI
- 10.1038/nm1337
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Our previous study demonstrated hypoxiaβinducible factorβ1(HIFβ1) could prompt multidrug resistance (MDR) phenotype and MGr1βAg/37LRP, a novel drugβresistance protein was reported by our labortary, associated with multidrug resistance in gastric cancer. Given this association, we hypoth
Accumulating studies demonstrate that the expressions of hypoxia-inducible factor 1 (HIF-1), erythropoietin (EPO) and vascular endothelial growth factor (VEGF) depend on cellular oxygen tension, which is involved in the pathological process of tissue hypoxia and/or ischemia. The present study invest
## Abstract Herβ2/__neu__ (__erb__Bβ2) oncogene overexpression is associated with increased tumor progression and metastasis. Fatty acid synthase (FAS), the key lipogenic enzyme responsible for the endogenous synthesis of fatty acids, has been shown to be one of the genes regulated by Herβ2/__neu__